SCHEMBL13067159

SCHEMBL13067159

C=C(C)/N=C(\C)SCc1ccccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.50
TAAR1 Q96RJ0 4/20 0.50
IDO1 P14902 3/20 0.50
HTT P42858 3/20 0.50
LMNA P02545 3/20 0.50
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.37
HPGD P15428 1/20 0.37
PNMT P11086 1/20 0.36
MAPT P10636 1/20 0.36
ALOX12 P18054 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13067268 0.83 SMN1; SMN2 (0.43) SMN1; SMN2TAAR1IDO1HTTLMNA
SCHEMBL2667321 0.81 TAAR1 (0.58) SMN1; SMN2TAAR1IDO1HTTLMNA
SCHEMBL13067317 0.80 LMNA (0.30) SMN1; SMN2TAAR1IDO1HTTLMNA
SCHEMBL12835100 0.75 TAAR1 (0.59) SMN1; SMN2TAAR1IDO1HTTLMNA
SCHEMBL15457417 0.74 IDO1 (0.68) SMN1; SMN2TAAR1IDO1HTTLMNA
SCHEMBL29034446 0.68 HTT (0.59) SMN1; SMN2TAAR1IDO1HTTLMNA
SCHEMBL13689952 0.67 PKM (0.53) SMN1; SMN2TAAR1IDO1HTTLMNA
SCHEMBL12835039 0.67 IDO1 (0.68) SMN1; SMN2TAAR1IDO1HTTLMNA
SCHEMBL13007579 0.67 IDO1 (1.00) SMN1; SMN2TAAR1IDO1HTTLMNA
SCHEMBL27592486 0.67 LMNA (0.68) SMN1; SMN2TAAR1IDO1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010132999-A1 METHYL SULFANYL PYRMIDMES USEFUL AS ANTIINFLAMMATORIES, ANALGESICS, AND ANTIEPILEPTICS CHLORION PHARMA, INC. (CA) 2010-11-25 WO disclosed